Skip to main content
. 2022 Jul 20;114(10):1347–1354. doi: 10.1093/jnci/djac112

Figure 1.

Figure 1.

Use of menopausal hormone therapy (MHT) or vaginal estrogen therapy (VET) in a cohort of Danish women treated for early-stage breast cancer (BC) according to adjuvant endocrine therapy. Use of MHT, VET, or no hormonal treatment (none) among patients with early-stage BC 1997-2004 according to use of adjuvant endocrine treatment.